Prostate Cancer Risk and Outcome in WTC respondents

世贸中心受访者的前列腺癌风险和结果

基本信息

项目摘要

DESCRIPTION (provided by applicant): An excess incidence of prostate cancer has been identified among World Trade Center (WTC) rescue and recovery workers included in the WTC Health Program (WTCHP) at Mount Sinai in New York. An excess has also been reported among WTC-exposed firefighters included in a separate program. It is unclear whether the excess is associated with WTC-related exposures or represents an artifact. Current understanding of the etiology and pathogenesis of prostate cancer - the most common cancer in US men - is limited, and an association between this cancer and WTC-related exposures would bear great importance for the WTCHP and beyond. Conversely, the finding that excess risk among WTCHP participants is not attributable to WTC related exposures, but to other factors (e.g., over-diagnosis because of enhanced surveillance and screening with prostate specific antigen [PSA]) would represent an important message to WTCHP members. The objectives of this project are to elucidate the reasons for the increased incidence of prostate cancer among WTCHP participants and to explore the behavior of these cancers. The project will complement an analysis of cancer risk according to WTC-related exposures that is already planned, by looking at other reasons for an increased prostate cancer risk and will investigate whether prostate cancers diagnosed among WTCHP participants differ from a clinical and molecular viewpoint from prostate cancers in WTC-unrelated patients. Specifically, the project will investigate clinical and epidemiological characteristics of prostate cancer in WTC responders and matched non-WTC prostate cancers: D'Amico risk score (comprising Gleason score and tumor stage); tumor size, nodal involvement, local and distant metastatic spread, PSA at diagnosis, as well as previous history of PSA testing will be compared between the two groups of patients. Molecular characteristics of the tumors will be studied through immunohistochemistry and molecular markers of inflammation in prostate cancer samples from WTCHP patients and matched non-WTC prostate cancers, to determine if tumors in WTCHP patients arise in a different "inflammatory" microenvironment. Finally, DNA methylation as a marker of tumor aggressiveness in tissue from WTCHP prostate cancer patients and in matched prostate cancers not related to WTC will be compared. The results will have practical implications on the surveillance and clinical management of prostate cancer, the most common cancer among male WTCHP members. The project will generate novel data on biomarkers of prostate cancer aggressiveness that could be used to make decisions on clinical treatment.
描述(由申请人提供):在纽约西奈山世贸中心健康计划(WTCHP)包括的世贸中心(WTC)救援和恢复工作人员中,发现前列腺癌发病率过高。据报道,在另一项计划中,接触WTC的消防员也出现了超标。目前尚不清楚超标是与WTC相关的暴露有关,还是代表着一种艺术品。前列腺癌是美国男性最常见的癌症,目前对其病因和发病机制的了解有限,这种癌症与WTC相关暴露之间的联系将对WTCHP和其他疾病具有非常重要的意义。相反,WTCHP参与者的过度风险不是由于WTC相关的暴露,而是其他因素(例如,由于加强监测和前列腺特异性抗原[PSA]筛查而过度诊断),这一发现将向WTCHP成员传达一个重要信息。该项目的目的是阐明WTCHP参与者前列腺癌发病率增加的原因,并探索这些癌症的行为。该项目将补充已经计划的根据WTC相关暴露对癌症风险的分析,通过寻找前列腺癌风险增加的其他原因,并将调查WTCHP参与者中被诊断为前列腺癌的患者是否从临床和分子角度与WTC无关患者的前列腺癌不同。具体地说,该项目将调查WTC应答者和匹配的非WTC前列腺癌的临床和流行病学特征:D‘Amico风险评分(包括Gleason评分和肿瘤分期);肿瘤大小、结节受累、局部和远处转移扩散、确诊时的PSA以及以前的PSA检测病史将在两组患者中进行比较。将通过免疫组织化学和炎症分子标志物研究WTCHP患者和匹配的非WTC前列腺癌患者前列腺癌样本中肿瘤的分子特征,以确定WTCHP患者的肿瘤是否发生在不同的“炎症”微环境中。最后,在WTCHP前列腺癌患者和与WTC无关的匹配前列腺癌患者的组织中,DNA甲基化作为肿瘤侵袭性的标志将进行比较。这一结果将对前列腺癌的监测和临床治疗具有实际意义。前列腺癌是WTCHP男性成员中最常见的癌症。该项目将产生前列腺癌侵袭性生物标记物的新数据,这些数据可用于临床治疗决策。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Prostate cancer characteristics in the World Trade Center cohort, 2002-2013.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EMANUELA TAIOLI其他文献

EMANUELA TAIOLI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EMANUELA TAIOLI', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10302837
  • 财政年份:
    2021
  • 资助金额:
    $ 45.07万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10686192
  • 财政年份:
    2021
  • 资助金额:
    $ 45.07万
  • 项目类别:
1/2- Feasibility study to build a collaboration in genetics and genomic cancer research
1/2- 建立遗传学和基因组癌症研究合作的可行性研究
  • 批准号:
    10686191
  • 财政年份:
    2021
  • 资助金额:
    $ 45.07万
  • 项目类别:
1/2- Feasibility study to build a collaboration in genetics and genomic cancer research
1/2- 建立遗传学和基因组癌症研究合作的可行性研究
  • 批准号:
    10302836
  • 财政年份:
    2021
  • 资助金额:
    $ 45.07万
  • 项目类别:
World Trade Center Tissue Biobank
世界贸易中心组织生物库
  • 批准号:
    9607412
  • 财政年份:
    2018
  • 资助金额:
    $ 45.07万
  • 项目类别:
Cancer Prevention and Control
癌症预防与控制
  • 批准号:
    10454172
  • 财政年份:
    2015
  • 资助金额:
    $ 45.07万
  • 项目类别:
Cancer Prevention and Control
癌症预防与控制
  • 批准号:
    10022664
  • 财政年份:
    2015
  • 资助金额:
    $ 45.07万
  • 项目类别:
Cancer Prevention and Control
癌症预防与控制
  • 批准号:
    10674512
  • 财政年份:
    2015
  • 资助金额:
    $ 45.07万
  • 项目类别:
Development of a vulnerability profile of the psychological sequelae of Hurricane
制定飓风心理后遗症的脆弱性概况
  • 批准号:
    9113131
  • 财政年份:
    2013
  • 资助金额:
    $ 45.07万
  • 项目类别:
Development of a vulnerability profile of the psychological sequelae of Hurricane
制定飓风心理后遗症的脆弱性概况
  • 批准号:
    8925234
  • 财政年份:
    2013
  • 资助金额:
    $ 45.07万
  • 项目类别:

相似国自然基金

中国北方人群肺癌患者Cancer/Testis抗原表达谱绘制表位鉴定及功能性抗原特异性CTL制备研究
  • 批准号:
    81673007
  • 批准年份:
    2016
  • 资助金额:
    54.0 万元
  • 项目类别:
    面上项目

相似海外基金

Urinary Phthalate Biomarker Concentrations and Breast and Prostate Cancer Risk in a National Cohort of Adults in Canada
加拿大全国成人队列中尿液邻苯二甲酸盐生物标志物浓度与乳腺癌和前列腺癌风险
  • 批准号:
    494953
  • 财政年份:
    2023
  • 资助金额:
    $ 45.07万
  • 项目类别:
    Operating Grants
Augmentation of PDE4D7 activity as a novel treatment strategy for men that have been stratified with high risk prostate cancer
增强 PDE4D7 活性作为针对高危前列腺癌男性的新型治疗策略
  • 批准号:
    2886779
  • 财政年份:
    2023
  • 资助金额:
    $ 45.07万
  • 项目类别:
    Studentship
Investigating mitochondrial dysfunction in high-risk prostate cancer
研究高危前列腺癌中的线粒体功能障碍
  • 批准号:
    10570345
  • 财政年份:
    2023
  • 资助金额:
    $ 45.07万
  • 项目类别:
Polygenic risk stratification combined with mpMRI to identify clinically relevant prostate cancer
多基因风险分层结合 mpMRI 来识别临床相关的前列腺癌
  • 批准号:
    10610626
  • 财政年份:
    2023
  • 资助金额:
    $ 45.07万
  • 项目类别:
Project 1: Tumor Microenvironment Initiators of the Metastatic Cascade in High-Risk Prostate Cancer
项目1:高危前列腺癌转移级联的肿瘤微环境启动因素
  • 批准号:
    10555400
  • 财政年份:
    2023
  • 资助金额:
    $ 45.07万
  • 项目类别:
Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles
使用超小二氧化硅纳米粒子进行高风险前列腺癌手术治疗的分子表型分析和图像引导
  • 批准号:
    10908927
  • 财政年份:
    2023
  • 资助金额:
    $ 45.07万
  • 项目类别:
Germline Genetics and Risk of Prostate Cancer in Diverse Populations from the All of Us Program
“我们所有人”计划中不同人群的种系遗传学和前列腺癌风险
  • 批准号:
    10798864
  • 财政年份:
    2023
  • 资助金额:
    $ 45.07万
  • 项目类别:
VIPCare: Virtual Predictive Care workflow with integrated surveillance for optimal care protocol selection and management in at-risk prostate cancer patients
VIPCare:虚拟预测护理工作流程,具有综合监测功能,可为高危前列腺癌患者提供最佳护理方案选择和管理
  • 批准号:
    10758350
  • 财政年份:
    2023
  • 资助金额:
    $ 45.07万
  • 项目类别:
Predicting Metastatic Progression of High Risk Localized Prostate Cancer
预测高风险局限性前列腺癌的转移进展
  • 批准号:
    10684561
  • 财政年份:
    2023
  • 资助金额:
    $ 45.07万
  • 项目类别:
Association between perfluoroalkyl substances and prostate cancer risk: A nested case-control study
全氟烷基物质与前列腺癌风险之间的关联:一项巢式病例对照研究
  • 批准号:
    23K09728
  • 财政年份:
    2023
  • 资助金额:
    $ 45.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了